)
HOYA (7741) investor relations material
HOYA Q2 2027 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Q2 FY2027 revenue reached a quarterly record ¥260,153 million, up 10.9% YoY; operating profit was ¥90,805 million, up 33.2%, supported by IT growth and improved Life Care profitability.
H1 revenue rose 13.4% to ¥515,895 million and operating profit increased 31.6% to ¥173,431 million.
Financial highlights
Q2 profit before tax was ¥91,591 million, up 27.3%; profit attributable to owners rose 27.6% to ¥70,709 million, and basic EPS increased to ¥211.85 from ¥161.96.
H1 profit attributable to owners increased 27.3% to ¥136,500 million; basic EPS was ¥408.44 versus ¥313.19.
Q2 profit from ordinary operating activities was ¥89,354 million, up 27.2%.
Segment performance
Q2 Life Care revenue grew 4.4% to ¥153,366 million and segment profit rose 25.8% to ¥32,585 million; OPM increased to 21.2% from 17.6%.
Eyeglass lens sales rose 8% (CC +1%), led by MIYOSMART and other value-added products; U.S. sales declined amid restructuring. IOL sales grew 5% (CC +1%).
Endoscope sales fell 10% (CC -16%) amid weakness in China and intensified competition in Europe and the U.S.; premium IOL sales grew in Japan and Europe.
Q2 IT revenue rose 23.4% to ¥106,787 million and segment profit increased 28.0% to ¥58,835 million; OPM was 55.1% versus 53.1% YoY.
H1 Life Care revenue was ¥308,154 million, up 8.5%, and profit was ¥62,569 million, up 24.8%; IT revenue rose 23.1% to ¥207,741 million and profit rose 27.9% to ¥114,451 million.
- Record revenue and profit growth, improved margins, and a ¥200bn share buyback announced.7741
Q1 2027 - Record revenue and profit, strong IT growth, new capital policy, and major capacity investments.7741
Q4 2026 - Record Q3 profit and revenue growth fueled by strong segments and one-time gains.7741
Q3 2026 - Record revenue, profit, and cash flow, with robust shareholder returns and ESG progress.7741
Q2 2026 - Record revenue and profit growth, driven by Life Care and IT, with a strong outlook ahead.7741
Q1 2026 - Information Technology drove double-digit profit growth despite Life Care's IT challenges.7741
Q1 2025 - Information Technology drove double-digit revenue growth, offsetting Life Care's medical challenges.7741
Q2 2025 - Record FY24 growth, new 40% dividend policy, and strong IT/Life Care performance.7741
Q4 2025 - Q3 profit before tax surged 31.3% on IT strength; full-year outlook remains strong.7741
Q3 2025
)
)
)
)
)
)
)
)